• This topic is empty.
Viewing 0 reply threads
  • Author
    Posts
    • #19452

      Janssen is asking the European Medicines Agency to approval ponesimod, an oral, selective S1P receptor 1 modulator, to treat RRMS and active SPMS. Read more here.

      What do you think of this news?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2020 All rights reserved.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account